3.95
Oncology Institute Inc stock is traded at $3.95, with a volume of 1.31M.
It is up +4.22% in the last 24 hours and up +29.51% over the past month.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.
See More
Previous Close:
$3.79
Open:
$3.91
24h Volume:
1.31M
Relative Volume:
0.72
Market Cap:
$369.34M
Revenue:
$361.07M
Net Income/Loss:
$-71.54M
P/E Ratio:
-5.00
EPS:
-0.79
Net Cash Flow:
$-47.97M
1W Performance:
+3.67%
1M Performance:
+29.51%
6M Performance:
+120.67%
1Y Performance:
+1,150%
Oncology Institute Inc Stock (TOI) Company Profile
Name
Oncology Institute Inc
Sector
Industry
Phone
562-735-3226
Address
18000 STUDEBAKER RD, CERRITOS
Compare TOI with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
TOI
Oncology Institute Inc
|
3.95 | 354.38M | 361.07M | -71.54M | -47.97M | -0.79 |
![]()
HCA
Hca Healthcare Inc
|
410.68 | 97.14B | 72.70B | 6.88B | 7.29B | 23.81 |
![]()
THC
Tenet Healthcare Corp
|
190.00 | 16.75B | 20.69B | 2.40B | 1.55B | 15.62 |
![]()
FMS
Fresenius Medical Care Ag Adr
|
27.41 | 15.74B | 21.23B | 924.30M | 2.22B | 1.2272 |
![]()
EHC
Encompass Health Corp
|
121.31 | 12.30B | 5.51B | 494.70M | 386.40M | 4.84 |
![]()
UHS
Universal Health Services Inc
|
197.76 | 12.48B | 16.08B | 1.20B | 1.06B | 17.82 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-23-25 | Initiated | Noble Capital Markets | Outperform |
Jul-16-25 | Initiated | B. Riley Securities | Buy |
May-15-25 | Initiated | BTIG Research | Buy |
Feb-26-24 | Resumed | Jefferies | Buy |
Sep-14-22 | Initiated | Guggenheim | Buy |
Aug-15-22 | Initiated | Jefferies | Buy |
View All
Oncology Institute Inc Stock (TOI) Latest News
Institutional scanner results for The Oncology Institute Inc.Weekly Trend Recap & Long-Term Safe Investment Plans - newser.com
Why The Oncology Institute Inc. Equity Warrant stock remains a top recommendation - newser.com
Using Python tools to backtest The Oncology Institute Inc. Equity Warrant strategiesQuarterly Trade Review & AI Driven Stock Movement Reports - newser.com
Will The Oncology Institute Inc. price bounce be sustainable2025 Macro Impact & Free Safe Entry Trade Signal Reports - newser.com
Has The Oncology Institute Inc. formed a bullish divergenceJuly 2025 Breakouts & Free Reliable Trade Execution Plans - newser.com
Will The Oncology Institute Inc. bounce back from current support2025 Year in Review & Free High Accuracy Swing Entry Alerts - newser.com
Is The Oncology Institute Inc. stock entering bullish territoryPortfolio Performance Summary & AI Driven Price Forecasts - newser.com
Is The Oncology Institute Inc. stock reversal real or fake2025 Dividend Review & Risk Managed Investment Strategies - newser.com
Is The Oncology Institute Inc. stock a safe buy before earningsJuly 2025 Catalysts & Free High Accuracy Swing Entry Alerts - newser.com
Will The Oncology Institute Inc. Equity Warrant stock recover after recent dropWeekly Stock Report & Safe Swing Trade Setups - newser.com
While institutions own 36% of The Oncology Institute, Inc. (NASDAQ:TOI), retail investors are its largest shareholders with 47% ownership - Yahoo Finance
How to manage a losing position in The Oncology Institute Inc.Dip Buying & Low Drawdown Trading Techniques - newser.com
Can technical indicators confirm The Oncology Institute Inc. Equity Warrant’s reversalJuly 2025 Big Picture & Safe Capital Growth Trade Ideas - newser.com
Heatmap analysis for The Oncology Institute Inc. Equity Warrant and competitorsWeekly Trade Review & Smart Investment Allocation Tips - newser.com
Momentum divergence signals in The Oncology Institute Inc. Equity Warrant chartTrade Performance Summary & Consistent Profit Focused Trading Strategies - newser.com
Sector ETF performance correlation with The Oncology Institute Inc.2025 Stock Rankings & Weekly Watchlist of Top Performers - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Oncology Institute (NASDAQ:TOI) - MarketBeat
Is The Oncology Institute Inc. Equity Warrant meeting your algorithmic filter criteria2025 Market Trends & High Accuracy Swing Entry Alerts - newser.com
Identifying reversal signals in The Oncology Institute Inc. Equity WarrantJuly 2025 Setups & Trade Opportunity Analysis Reports - newser.com
Can volume confirm reversal in The Oncology Institute Inc. Equity WarrantQuarterly Risk Review & Daily Chart Pattern Signal Reports - newser.com
Oncology Institute at Noble Capital: Strategic Growth and Profitability Goals By Investing.com - Investing.com Canada
The Oncology Institute Inc Stock Analysis and ForecastBear Market Strategies & Stay Safe With Built-In Risk Monitoring - earlytimes.in
What analysts say about The Oncology Institute Inc stockEarnings Per Share Trends & Try Our Free Strategy Builder Now - earlytimes.in
Real time social sentiment graph for The Oncology Institute Inc. Equity Warrant2025 Technical Patterns & Risk Controlled Swing Alerts - newser.com
The Oncology Institute Inc. stock trendline breakdownEarnings Growth Summary & Weekly Market Pulse Updates - newser.com
Is The Oncology Institute Inc. trending in predictive chart modelsJuly 2025 Short Interest & Growth Focused Entry Reports - newser.com
Can machine learning forecast The Oncology Institute Inc. recoveryQuarterly Performance Summary & High Yield Equity Trading Tips - newser.com
Is The Bombay Burmah Trading Corporation Limited Stock Set to Outperform Its Peers in YEAR - earlytimes.in
Will The Oncology Institute Inc. Equity Warrant stock benefit from green energy trendsMarket Risk Analysis & Reliable Price Action Trade Plans - newser.com
Relief Rally in The Oncology Institute Inc. Stock — Can It HoldJuly 2025 Action & Low Risk High Win Rate Stock Picks - metal.it
What analysts say about The Oncology Institute Inc Equity Warrant stockUtilities Sector Analysis & Big Profit Small Capital - earlytimes.in
The Oncology Institute to Participate in the Noble Capital Markets Emerging Growth Virtual Equity Conference - 富途牛牛
Rogel Cancer Center - University of Michigan Health
Value-Based Oncology Pioneer TOI Leadership to Present at Noble Capital Markets Conference - Stock Titan
Can The Oncology Institute Inc. Equity Warrant stock beat analyst upgrades2025 Historical Comparison & Reliable Trade Execution Plans - newser.com
DGX's Haystack Oncology Teams Up With Rutgers Cancer Institute - Yahoo Finance
Goldman Sachs Group Inc. Invests $131,000 in The Oncology Institute, Inc. $TOI - Defense World
Oncology Institute Inc Stock (TOI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Oncology Institute Inc Stock (TOI) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
M33 Growth I L.P. | Director |
Sep 04 '25 |
Sale |
3.09 |
681,832 |
2,106,861 |
590,892 |
Hively Brad | Director |
Aug 19 '25 |
Sale |
4.06 |
20,221 |
82,097 |
622,980 |
M33 Growth I L.P. | Director |
Jun 05 '25 |
Sale |
3.05 |
673,676 |
2,054,712 |
13,950,557 |
M33 Growth I L.P. | Director |
Jun 05 '25 |
Sale |
3.05 |
76,324 |
232,788 |
1,272,724 |
Hively Brad | Director |
Jun 03 '25 |
Option Exercise |
0.90 |
1,867,605 |
1,682,524 |
2,579,638 |
Hively Brad | Director |
Jun 03 '25 |
Sale |
2.87 |
1,976,137 |
5,672,106 |
603,501 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):